Pios, Jesa Mae N.
HRN: 23-51-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2025
CEFUROXIME 500MG (TAB)
01/17/2025
01/24/2025
ORAL
500
BID
SP NSVD WITH RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes